Screener
Zevra Therapeutics, Inc. ZVRA Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Property and equipment, net | 641 | 489 |
| Operating lease right-of-use assets | 1,667 | 1,212 |
| Goodwill | 4,701 | 4,701 |
| Intangible assets, net | 5,789 | 6,421 |
| Other long-term assets | 3 | 143 |
| Total assets | $302,712 | $284,731 |
| Liabilities and stockholders' equity | ||
| Current liabilities: |
ITEM 1.FINANCIAL STATEMENTS
FAQ
- What is Zevra Therapeutics, Inc.'s intangibles (net)?
- Zevra Therapeutics, Inc. (ZVRA) reported intangibles (net) of $5.79M in Q2 2026.
- How has Zevra Therapeutics, Inc.'s intangibles (net) changed year-over-year?
- Zevra Therapeutics, Inc.'s intangibles (net) decreased by 17.9% year-over-year, from $7.05M to $5.79M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.
Ask your AI about Zevra Therapeutics, Inc.'s intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude